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Abstract 
Thyroid hormone is critical to the regulation of development, growth, and metabolism 
and is released from the thyroid gland in two forms, T3 and T4. T3 movement into the cell 
allows it to bind thyroid hormone receptor (TR) in the cytoplasm or nucleus, and this 
hormone-receptor complex can regulate gene expression by enhancing or repressing 
transcription at thyroid hormone response elements (TREs). Alternative splicing creates 
six specific isoforms of TR that vary in their localization and ability to bind T3 and TREs. 
The two main isoforms of TR are TRα and TRβ. The necessity of TR for hormone-
dependent regulation is complicated by TR nucleocytoplasmic shuttling; proper TR 
shuttling dynamics allow for the nuanced patterns of gene expression observed in 
development, growth and metabolism. TR shuttling into and out of the nucleus is 
mediated by importins that recognize nuclear localization signal (NLS) motifs and 
facilitate nuclear import, and exportins that recognize nuclear export signal (NES) motifs 
and facilitate nuclear export. While TR may be partially dependent on the general 
CRM1/calreticulin cooperative nuclear export pathway, previous studies have suggested 
that TR uses an alternative exportin 5-mediated nuclear export pathway as well. 
Elucidating the impact of exportin 7 (XPO7), a recently discovered exportin with a broad 
substrate specificity, on TR nuclear export was one of the primary objectives of this 
thesis research. To assess the impact XPO7 had on TR localization, transient 
transfections of HeLa cells with XPO7 were performed and TR distribution was 
examined by fluorescence microscopy. CAT ELISAs and measurement of TRE-CAT 
reporter gene expression under conditions of XPO7 overexpression also served as an 
indicator of TR presence in the nucleus. Localization data from fluorescence microscopy 
showed that overexpression of XPO7 shifted TR from a predominantly nuclear to either a 
nuclear and cytoplasmic or whole cell distribution, suggesting that XPO7 plays a central 
role in TR cellular localization. Analysis of transcriptional activity from CAT ELISAs 
proved less direct as TRα-transfected cells overexpressing XPO7 had a large amount of 
variability, with XPO7 overexpressing cells demonstrating both higher and lower levels 
of CAT reporter gene expression under control of a TRE relative to control cells, in 
contrast TRβ-transfected cells overexpressing XPO7 having significantly higher CAT 
reporter gene expression under control of a TRE relative to control cells. Another aspect 
of this thesis research involved assessing the possible regulatory role of the Ubiquitin-
Proteasome Pathway (UPP) on T3-responsive gene expression, as preliminary studies 
indicated that ubiquitinated and liganded TRα is bound to chromatin. CAT ELISAs 
performed under conditions of proteasome inhibition and ubiquitin overexpression 
proved inconclusive. Further investigation is required to better comprehend the 
relationship between the UPP and T3–mediated gene expression. 
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Introduction 
Overview  
 The cellular and organismal functions dependent on normal thyroid hormone 
synthesis, transport, and intracellular interaction with thyroid hormone receptor (TR) are 
extensive and encompass a wide range of systems in all vertebrates. Thyroid hormone is 
essential to development, growth, and metabolism; a more specific list of some of its 
functions includes the processes of neural development, pulmonary function, skeletal 
development and establishment of peak bone mass, various immune processes, cardiac 
contractility and metabolism of sugars, fats, and proteins (Brent, 2012). Regulation of 
thyroid hormone synthesis occurs via feedback control along the hypothalamic-pituitary-
thyroid axis. Thyrotropin-releasing hormone (TRH) released from the hypothalamus 
causes the release of thyroid stimulating-hormone (TSH) from the anterior pituitary 
gland. TSH acts on the follicular cells of the thyroid gland to cause thyroid hormone 
release. The thyroid gland produces two forms of thyroid hormone: triiodothyronine (T3) 
and thyroxine (T4). T4 is a prohormone and the major form of thyroid hormone 
circulating in the bloodstream; it is structurally homologous to T3, with the exception of 
the presence of a fourth iodine. Removal of one iodine from T4 creates the active 
hormone, T3, which has a higher binding efficiency to TR than the prohormone (Brent, 
2012).  
 TRs modulate patterns of gene expression when bound and unbound to ligand. 
Two main isoforms of TR, TRα and TRβ, are essential parts of this regulatory complex, 
shuttling in and out of the nucleus and binding ligand. Nucleocytoplasmic shuttling is a 
complex process; generally only proteins with nuclear localization signal (NLS) or 
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nuclear export signal (NES) motifs can be transported in and out of the nucleus by 
importin and exportin members of the karyopherin β family through nuclear pore 
complexes. TR has multiple NESs: a highly conserved NES in helix 12 of its ligand-
binding domain and either one or two NESs between helices 3 and 6 of the ligand-
binding domain (Mavinakere et al., 2012). Both CRM1-dependent and CRM1-
independent pathways are used to facilitate nuclear export of TR.  
 Elucidation of the mechanisms of TR nuclear export is critical to understanding 
many of the conditions caused by disregulation of normal nucleocytoplasmic trafficking 
patterns, including certain types of cancer. Atypical shuttling profiles can also impact 
transcription, as nuclear TR availability is a prerequisite for transcriptional regulation of 
T3-responsive genes (Liu and Brent, 2010). TR availability, and thus, transcriptional 
activity at thyroid hormone response elements (TREs) is also dependent on rates of 
receptor degradation through the ubiquitin-proteasome pathway. Hypothetically, both 
proteasome inhibition and overexpression of ubiquitin would impact levels of gene 
expression at TREs. Beyond their roles in degradation, some of the enzymatic 
components of the ubiquitin-proteasome pathway are also capable of acting as 
coactivators, further complicating investigation of the impact of the ubiquitin-proteasome 
pathway on transcriptional regulation.  
 The major objectives of this thesis research were to explore the effect of 
overexpression of exportin 7 on the cellular localization of TR, and to investigate the 
transcriptional activity of T3-responsive genes when exportin 7 is overexpressed and 
when the ubiquitin-proteasome pathway is manipulated. 
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Nuclear Receptors 
 
Regulation of gene expression is partially facilitated through hormone signaling. 
Hormones travel in the blood from their site of production in the body, either freely or 
bound to carrier proteins dependent on their solubility, and enter a cell by a variety of 
methods, binding cognate nuclear receptors (NRs) at the cell surface or within the cell. 
The hormone-NR complex exerts control over transcription by binding to specific 
hormone response elements in the regulatory regions of hormonally-responsive target 
genes to stimulate or repress transcription.  
 As hydrophilic and lipophilic hormones exist and can vary in derivation from 
peptides, amino acids, and steroids, a variety of functionally diverse cognate NRs serve 
as the link between signaling hormone and transcriptional response (Brent, 2012). There 
are three NR classes: Class I contains receptors for steroid hormones, like progesterone 
and glucocorticoid receptors; Class II is the thyroid/retinoid family, including the thyroid 
hormone and retinoic acid receptors; and Class III comprises the orphan receptors, unique 
members of the superfamily, classified as receptors on the basis of their sequence 
homology with known receptors but lacking a known ligand (Bain et al., 2006). Class I 
receptors are bound to heat shock proteins and immunophilins in the absence of their 
ligands and are cytoplasmically sequestered. Ligand binding in Class I receptors induces 
nuclear translocation, homodimerization, and binding to imperfect palindromic response 
elements at upstream regulatory sites. Binding at these imperfect palindromic response 
elements is coupled to coactivator recruitment, including members of the p160 family 
(Xu and Li, 2003), resulting in either repression or activation of target gene transcription. 
Class II receptors generally heterodimerize with other Class II NRs, and bind direct, or 
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palindromic, response elements both in the presence and absence of ligand (Ribeiro, 
1995; Aranda and Pascual, 2001; Eckey et al., 2003; Bain et al., 2006). Although binding 
of Class II NRs to response elements in the absence of ligand typically results in 
transcriptional repression, corepressors like silencing mediator for retinoic acid and 
thyroid hormone receptors (SMRT) and nuclear corepressor (NCoR) also cause 
transcriptional repression and can be displaced by ligand binding, inducing 
transcriptional activation (Collingwood et al., 1999). 
The basis for similarity of response in different NRs is conserved regions shared 
amongst all NRs: the distinctive and variable length amino-terminal domain (A/B), DNA-
binding domain (DBD or C), hinge region (D), and the carboxy-terminal ligand-binding 
domain (LBD or E). The N-terminal region generally ranges from less than 50 to 500 
amino acids and contains a transcriptional activation domain (AF-1) and multiple 
independent transactivation domains (Robinson-Rechavi et al., 2003; Collingwood et al., 
1999). The DBD mediates NR hetero- or homodimerization and DNA-binding specificity 
to particular hormone response elements; a number of spatially resolved DBD structures 
for different NRs have revealed a conserved region containing two zinc fingers that 
chelate two Zn2+ ions. Between the DBD and LBD lies a sequence-flexible hinge region 
containing a nuclear localization signal (NLS) that crosses into the DBD in some cases. 
The largest region, the LBD, is intermediate in primary sequence conservation between 
the DBD and hinge region. Interestingly, the LBD has highly conserved secondary 
structure amongst different NRs with 12 α-helices present, facilitating a wide variety of 
functions in addition to hormone binding, including transactivation through the AF-2 
domain, dimerization through strong dimerization interfaces, NLS or NES motifs in some 
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cases, and often a domain with repression capabilities (Robinson-Rechavi et al., 2003; 
Mavinakere et al., 2012). 
 
Thyroid Hormone 
 
Thyroid hormone (TH) is integral in pathways involving growth, differentiation, 
and metabolism. The brain, liver, skeletal muscles and heart, and adipose tissue depend 
on TH for wide-ranging functions like apoptosis, neuroblast mitosis, neuronal 
proliferation, differentiation, lipogenesis, and lipolysis. Misregulation of endocrine 
signaling involving TH may have a number of deleterious effects including mental 
retardation, obesity, metabolic disorders, and a number of cancers, as TH is involved in 
numerous cross-talk pathways (Liu and Brent, 2010).  
 Negative feedback loops regulate TH production in follicular cells of the thyroid 
gland. Thyrotropin-releasing hormone from the hypothalamus travels to the anterior 
pituitary to cause the release of thyroid stimulating hormone (TSH) from the anterior 
pituitary. TSH and the TSH receptor on the follicular cell basolateral membrane facilitate 
iodide uptake with a sodium/iodide symporter, followed by a series of steps necessary for 
TH synthesis and secretion (Brent, 2012). Iodination of tyrosine residues in the 
glycoprotein thyroglobulin yields two forms of the hormone, active triiodothyronine (T3) 
and the prohormone thyroxine (T4). T3 and T4 are physically homologous with the 
exception of a fourth iodine on T4, which is primarily removed by type 2 5′-deiodinase 
(D2) in humans, regulated by a ubiquitinase/deubiquitinase mechanism. T4 deiodination 
by D2 leads to exposed lysine residues in D2: ubiquitination of these residues reduces D2 
activity, and deubiquitination increases D2 activity (Sagar et al., 2008; Bianco, 2011). 
Type 3 5’-deiodinase (D3) provides another important regulatory pathway for TH 
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signaling as D3 mediates T4 inactivation to reverse T3 as a means of eliminating excess 
T4 (Hernandez et al., 2007; Ng et al., 2010). The predominant form of TH produced by 
the thyroid gland is T4 which circulates freely or bound to the carrier proteins thyroxine-
binding globulin, transthyretin or albumin (Palha, 2005). Lipophilic thyroid hormone 
enters the cell through specific membrane transport proteins and non-amino acid specific 
transporters, including the monocarboxylate (MCT) family and organic anion transporters 
(OATPs) (Visser et al., 2011). MCT8 and MCT10 facilitate bidirectional TH transport 
across the plasma membrane. Human expression of MCT8 is predominantly in the brain 
including the cerebellar cortex and hippocampus and is present in different parts of the 
human hypothalamus and folliculostellate cells of the anterior pituitary. MCT10 is 
predominantly expressed on the basolateral membrane of the intestine, kidney, liver, 
muscle, and placenta. OATP1C1 has higher expression levels in the human brain and in 
Leydig cells of the testis and brain capillaries in rats and mice (Visser et al., 2011). 
These transporters can facilitate T4 and T3 passage into the cell. Unliganded 
thyroid hormone receptor (TR) heterodimerizes with retinoid X receptor (RXR) or 
homodimerizes and binds to a thyroid hormone response element (TRE). RXR-TR 
heterodimerization occurs through their LBDs, although TR dimerization also occurs 
through the DBD (Kakizawa et al., 1997).  This hetero- or homodimeric complex may, in 
some cases, stimulate gene expression at negative TREs or, more commonly, bind 
corepressors, such as NCoR or SMRT, to repress gene expression at positive TREs 
(Brent, 2012). Generally T3 signaling and transcriptional control occurs through T3 
binding to the LBD of TR, resulting in movement of C-terminal helix 12, disruption of 
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corepressor binding, and promotion of coactivator binding, which then leads to 
recruitment of RNA polymerase II and transcription initiation (Brent, 2012). 
 
Thyroid Hormone Receptor 
 
Two different genes, THRA, located on human chromosome 17, and THRB, 
located on human chromosome 3, encode TRs, and produce multiple TR isoforms 
through alternative splicing (Nagaya et al., 1996). There are four ligand-binding 
isoforms: TRα1, TRβ1, TR2, and TRβ3. TRα1 and TRα2 are created by alternative 
splicing of the THRA gene, their amino acid sequences are identical until residue 370 in 
the LBD. TRα2 and TRα3 do not bind T3, although alternative splicing of TRα creates 
additional truncated forms with varying ligand-binding ability. Different TRβ transcripts, 
varying in their N-terminal domains, are created through alternative promoter regions 
(Oetting and Yen, 2007). The different TR isoform sequences and structures lend to 
tissue-specific responses and variable signal transduction pathways that allow TR to 
function in multiple cross-talk capacities. TRα1, TRβ1, and TRβ2 have highly 
homologous DBDs and LBDs. The isoforms bind T3 with similar affinity and can 
recognize common artificial consensus TREs in vitro (Chan and Privalsky, 2009). 
However, all of the TR isoforms have different primary sequence with resulting distinct 
folded conformations.  
Isoform expression varies along a developmental, tissue-specific and temporal 
axis. TRα1 is expressed very early in development and is found in most adult tissues, 
whereas TRβ1 is expressed later in fetal development (Chan and Privalsky, 2009). TRα1 
is primarily expressed in heart and skeletal muscle. TRβ1 has a wide expression range, 
while TRβ3 is principally expressed in kidney, liver, and lung. TRβ2 is the most common 
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isoform expressed in the retina and inner ear, while the brain seems to principally express 
both TRβ2 and TRα1. The viral protein v-ErbA is a mutant version of TRα1, lacking 
helix 12 in the LBD, preventing T3 binding, and bearing other cancer-promoting features 
(Brent, 2012). 
As TR is an NR, all isoforms contain the N-terminal domain and a variable AF-1 
transactivation domain, the strictly conserved DBD, hinge domain, and LBD. The 
variable AF-1 region augments transcription activation, the DBD aids in TRE binding 
and dimerization, the LBD binds ligand and houses NES activity, and the hinge domain 
contains a bipartite NLS. TRα1 houses a second NLS in the A/B domain (Mavinakere et 
al., 2012). 
 
Localization and Shuttling 
 
TR is a unique NR in that it can bind target genes both in the presence and 
absence of ligand (Zhang and Lazar, 2000). This impacts the nucleocytoplasmic shuttling 
profile of TR and its role as a transcriptional regulator. Unliganded TR bound to a 
positive TRE generally represses transcription by recruiting corepressors like NCoR or 
SMRT and histone deacetylases. T3 binding to TR induces conformational changes in TR 
and transcriptional activation through the release of corepressors and recruitment of 
coactivators like CBP/p300, pCAF, and steroid receptor coactivator-1 (SRC-1) (Kim et 
al., 2005). p300 and CBP are highly related histone acetyltransferases that interact with 
SRC-1, but also bind independently to NRs in a ligand-dependent manner (Chakravarti et 
al. 1996). p300 and CBP can enhance ligand-dependent transcriptional activation in 
collaborative interaction with SRC-1 (Smith et al. 1996). p300, CBP and SRC-1 also 
interact independently with PCAF (Yang et al. 1996, Torchia et al. 1997, Blanco et al. 
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1998) leading to the hypothesis that a large histone acetyltransferase factory might be 
assembled near ligand-bound receptors (Wade et al. 1997). The necessity of TR presence 
in forming a functional regulatory complex suggests a constitutive nuclear localization, a 
hypothesis which was disproven by the experimental discovery that TR shuttles rapidly 
between the nucleus and cytoplasm (Bunn et al., 2001). Under homeostatic conditions, 
TRα1 has about a 90% nuclear localization while TRβ1 has about an 85% nuclear 
localization. 
 Movement in and out of the nucleus through the water-impermeable, double- 
membrane, phospholipid bilayer nuclear envelope occurs through restrictive nuclear pore 
complexes (NPC) embedded in the envelope (Lodish, 2000). The NPC allows 
translocation of cargo through a central channel. Cargo moving through this central 
channel interacts with phenylalanine (F) and glycine (G)-repeats that form a semi-
permeable barrier allowing relatively uninhibited passage of small molecules of 
approximately <40-60 kDa, while blocking the passage of larger molecules and 
preventing diffusion of macromolecules in and out of the nucleus. In addition to size, the 
hydrophobicity of F and G presents another impediment to the import of potential cargo. 
Cargo larger than 40-60 kDa must be escorted through NPCs with the help of transport 
proteins belonging to the karyopherin β family (Lodish, 2000). The karyopherin family is 
comprised of importins and exportins. The maintenance of convoluted nucleocytoplasmic 
trafficking patterns also depends on an asymmetric distribution of RanGTP, with higher 
concentrations in the nucleus and lower concentrations in the cytoplasm. 
In the classical model of nuclear import, cargo bearing a short, positively-charged 
NLS binds a heterodimer of importin α and importin β1. Importin α acts as an adaptor, 
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recognizing and binding the NLS, and binds to importin β1 through an N-terminal 
importin β1 binding domain (IBB). Importin β1 facilitates nuclear import through direct 
interactions with FG repeats in the NPC (Bayliss et al., 2000). Disassociation of the 
nuclear import complex, enabling release of the cargo protein with an NLS, depends on 
RanGTP binding to importin β1 and the exportin CAS binding to importin α. The 
importin β1–RanGTP complex can return to the cytoplasm through the NPC. Both CAS 
and RanGTP are required to facilitate cytoplasmic recycling of importin α (Kutay et al., 
1997). Cytoplasmic RanGAP, or Ran GTPase-activating protein, dissociates these 
complexes by stimulating GTP hydrolysis, converting RanGTP to RanGDP and freeing 
the importins for another import cycle. Cytoplasmic RanGDP is imported into the 
nucleus by nuclear transport factor-2 (NTF2), where RanGEF, or Ran guanine 
nucleotide-exchange factor, catalyses the exchange of GDP for GTP and replenishes the 
pool of nuclear RanGTP (Stewart, 2008). Nucleocytoplasmic shuttling is convoluted 
because there are a wide variety of cargoes with NLSs or NESs specific to certain 
members of the karyopherin β family, 20 of which are present in human cells. 
Furthermore, there are more cargoes with differently structured NLSs or NESs than 
karyopherins (Pemberton and Paschal, 2005).  
Nuclear export presents a similar enigma in the sense that there seem to be many 
possible NESs with many possible structures binding karyopherins to create a viable 
export complex. One of the most well characterized exportins that TR has been shown to 
be partially reliant on for nuclear export is CRM1, the major karyopherin for the export 
of proteins out of the nucleus, as well as many RNAs. CRM1 mediates nuclear export of 
hundreds of proteins through the recognition of the leucine-rich NES (Dong et al., 2009). 
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Other well known exportins, are exportins 5 and 7, which have been demonstrated to 
facilitate nuclear export of microRNA precursors and p50RhoGAP/14-3-3σ, respectively 
(Nelson, 2013). In a typical nuclear export model, RanGTP serves as the bridge between 
cargo bearing an NES and an exportin. This ternary complex can move to the cytoplasm 
through the NPC where a cytoplasmic RanGAP stimulates GTP hydrolysis, causing the 
complex to disassociate, leaving the cargo in the cytoplasm. The exportin can then re-
enter the nucleus to facilitate another round of nuclear export (Lodish, 2000).  
Nucleocytoplasmic shuttling is crucial to the transcriptional regulation activities 
of TR. Certain sequences in the full-length protein, NLS and NES motifs, enable this 
bidirectional nuclear transport. TRα1 is unique in its possession of an additional NLS in 
the N-terminal domain accompanying the more ubiquitous hinge domain NLS. This N-
terminal NLS is inert in v-ErbA and absent in TRβ1; however, it is necessary for efficient 
TRα1 nuclear import and retention. A completely nuclear localization of TRα1 in 
homeostatic conditions requires the N-terminal domain, DBD, and hinge domain, 
indicating that TR nuclear import relies on an interplay between multiple domains and 
NLSs. The impact of other factors like NCoR or RXR, which enhance nuclear retention 
of TRβ1, complicates the nuclear import model and demonstrates the intricacy of the 
possible interactions (Mavinakere et al., 2012). TR is thought to use both the classical 
nuclear import model, with an importin α1 adaptor protein and importin β1, and a non-
classical model where importin 7 binds TR and facilitates nuclear import. (Roggero et al., 
unpublished data; Parrente, 2010) 
For nuclear export, previous studies have shown that TRα1 makes use of a 
cooperative export pathway involving chromosome region maintenance 1 (CRM1) and 
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calreticulin as an adaptor protein. The dearth of leucine-rich NESs typically employed by 
CRM1 in TRα1 and the inability of leptomycin B (LMB) to completely inhibit nuclear 
export spurred investigation into alternative exportins that could facilitate TR nuclear 
export (Grespin et al., 2008). Multiple CRM1-independent NESs have been identified in 
the LBD of TR: one at helix 12 and either one or two more between helix 3 and helix 6 
(Mavinakere et al., 2012). Exportin 5 plays a role in one of these CRM1-independent 
pathways by influencing TR localization (Nelson, 2013). Investigating the role of 
exportin 7 in mediating CRM1-independent export of TR is a primary focus of this thesis. 
 
Exportin 7 Structure and Function 
 Exportin 7 (XPO7) was first identified by using Ran affinity chromatography on 
HeLa cell extracts. Immobilized RanQ69L, a GTPase-deficient mutant of Ran that stays 
bound to GTP regardless of the presence of RanGAP, was used to identify proteins 
interacting with RanGTP, specifically. SDS-PAGE and peptide sequencing revealed 
peptides corresponding to known transport receptors (Kutay et al., 2000). The presence of 
an importin β-like RanGTP-binding domain was suggested by sequence information and 
comparison to expressed sequence tags, which demonstrated remarkable similarity to an 
open reading frame from C. elegans that is homologous to the N-terminal regions of 
known importins and exportins. Using sequencing information from the C. elegans 
protein, full-length XPO7 cDNA was created. Western blotting with antibodies to a C-
terminal peptide of XPO7 revealed enrichment in the RanGTP-bound fraction.  
 Sequence alignments place XPO7 in a distant part of the evolutionary tree, 
distinct from the rest of the importin β superfamily. As an example, homology between 
XPO7 and its closest relative, CRM1, is limited to the N-terminal RanGTP-binding 
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domain. However, there are multiple lines of evidence validating the inclusion of XPO7 
in the importin β related nuclear transport receptor superfamily: direct interaction of 
XPO7 with RanGTP, its predominantly nuclear and nuclear envelope localization in 
living cells, direct binding of XPO7 to a nucleoporin implicated in translocation of 
transport receptors, and the ability to enter the nucleus without the help of any other 
soluble factors (Kutay et al., 2000). 
The x-ray crystallographic structure of XPO7 has yet to be characterized; 
however, further studies have shown the highest XPO7 expression in testis, thyroid, and 
bone marrow. XPO7 has low expression in lung, liver, and small intestine, and no 
expression in thymus. There is moderate XPO7 expression in other tissues (Koch et al., 
1999). XPO7 is also expressed in red blood cells and overexpressed in the cytoplasmic 
fraction of red blood cells in patients with hereditary non-spherocytic hemolytic anemia 
(von Lohneysen et al., 2011). 
XPO7 mediates a general nuclear export pathway with cargoes ranging from 14-
3-3σ (cytoplasmic anchor for cyclin-dependent kinases), p50RhoGAP (a GTPase-
activating protein for Rho- and Rac-GTPases), STRADα (a regulator of LKB1, a 
serine/threonine kinase), and E2A (transcription factors of the basic-loop-helix family) 
(Mingot et al., 2004; Lee et al., 2010). This broad substrate specificity is especially 
interesting in light of the departure of XPO7-dependent NESs from a classical leucine-
rich NES. XPO7-dependent NESs generally contain basic residues and folded motifs, 
although XPO7 has been demonstrated to facilitate export of cargoes containing a 
classical NES in some cases (Mingot et al., 2004; Caceres-Gorriti et al., 2014). 
Conversely, an intermediate disassociation constant for RanGTP hydrolysis has led to 
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ambiguity in the classification of XPO7 as an importin or exportin, and the proposal that 
it may mediate bidirectional transport (Kutay et al., 2000). The dependence of all the 
cargoes listed above, with the exception of E2A, on a cytoplasmic localization for 
function, enhances the probability of XPO7 acting primarily as an exportin. 
 In accordance with the presence of multiple basic residues in XPO7-dependent 
NESs, E2A transcription factors are members of the basic helix-loop-helix (bHLH) 
protein family, characterized by high-density regions of positively charged amino acids. 
The nuclear presence of E2A proteins, including alternative splicing products E12 and 
E47, is required for their normal function as transcription factors. It has been shown that 
XPO7 increases E2A transcriptional activation and that E12 and XPO7 co-
immunoprecipitate, further supporting the idea that positive residues increase the 
likelihood of cargo binding with XPO7, and that the exportin may noticeably impact the 
transcriptional activity of binding partners that participate directly or indirectly in 
transcription. The binding between E12 and XPO7 has been demonstrated as being 
direct; however, the interaction of E2A proteins with p300/CBP and SAGA histone 
acetyltransferase complex demonstrates how complicated the transcriptional regulation 
can become with synergistic and competitive elements influencing transcriptional activity 
(Lee et al., 2010). 
 As demonstrated by its upregulation of E2A-XPO7 genes, including the cyclin-
dependent kinase inhibitor p21Waf1/Cip1, and cytoplasmic sequestration of negative 
regulator of cell cycle 14-3-3σ, the impact of XPO7 on crucial cellular housekeeping 
activities may extend to cell cycle control. 14-3-3σ requires cytoplasmic localization to 
sequester the cdc2-cyclin B1 complex in the cytoplasm, which results in G2 arrest (Holm 
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et al., 2009); cytoplasmic p21Waf1/Cip1 orchestrates G1 arrest in response to low-level 
DNA damage, giving the cell time to repair the damage before resuming cycle 
progression (Lodish, 2000). Both p21Waf1/Cip1 and 14-3-3σ are p53-inducible genes, with 
14-3-3σ acting in a positive feedback loop with p53 where 14-3-3σ expression leads to 
stabilized expression of p53. 14-3-3σ acted antagonistically towards Mdm2 by blocking 
Mdm2-mediated p53 ubiquitination and nuclear export. Other effects of 14-3-3σ on p53 
stability encompass facilitation of the oligomerization of p53 and enhancement of p53 
transcriptional activity. In turn, stabilized p53 can carry out its cell cycle regulatory 
activities (Yang et al., 2003). Thus, the direct (14-3-3σ cytoplasmic sequestration) and 
indirect (upregulation of E2A target gene p21Waf1/Cip1)  influence of XPO7 on cell cycle 
regulation is significant. 
 In addition to p53, XPO7 regulates another master tumour suppressor, LKB1, 
involved in cell polarity, metabolism, and cell growth. Two binding partners control the 
compartmental distribution of LKB1: STRADα, a direct XPO7 substrate, and Mo25. 
STRADα competitively inhibits LKB1 binding to importin-α/β, anchors the kinase in the 
cytoplasm, and facilitates nuclear export of LKB1 by serving as an adaptor between 
LKB1 and CRM1 or XPO7. Mo25 stabilizes the STRADα-LKB1 complex (Dorfman and 
Macara, 2008). LKB1 represents a major regulatory checkpoint within the cell as it is a 
serine/threonine kinase that directly phosphorylates and activates 13 protein kinases in 
the AMPK family, which includes vital metabolic sensors (Shackelford and Shaw, 2009). 
AMPK regulates lipid, cholesterol and glucose metabolism in specialized metabolic 
tissues such as liver, muscle, and adipose and it has been experimentally demonstrated 
that treatment with thyroid hormone increases LKB1 and Mo25 muscle content leading to 
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increased AMPK activation (Branvold et al., 2008). Importantly, LKB1 has a primarily 
nuclear distribution.  The expression of STRADα, the presence of XPO7, and to a lesser 
degree, Mo25 facilitate stimulation of catalytic activity and cytoplasmic translocation of 
LKB1, which then can prompt spontaneous cell polarization in intestinal epithelial cells 
in the absence of cell-to-cell contacts. Nuclear-localized LKB1 mutants incapable of 
stable binding with STRADα have been found in cases of Peutz-Jeghers cancer 
syndrome, further reinforcing the impact of nucleocytoplasmic distribution on proper 
function (Dorfman and Macara, 2008).  
 The use of both XPO7 and CRM1 in STRADα nuclear export is interesting in 
many regards. CRM1 acts as the major STRADα exportin, binding to a short, linear, 
leucine-rich NES. The NES that mediates STRADα-XPO7 interaction is multipartite, 
requiring both N- and C-termini in addition to the classical NES used by CRM1 
(Dorfman and Macara, 2008). The highest expression of XPO7 in the testis, thyroid, and 
bone marrow (Koch et al., 2000) suggests that the use of both exportins allows 
development of nuanced temporal and spatial regulation in a tissue-specific manner. This 
hypothesis seems more plausible when considered with the observation that XPO7 is one 
of only three differentially expressed genes in the process of terminal erythroid 
differentiation, indicating a complex role in signaling (Koury et al., 2007). 
 
Ubiquitination-Proteasome Pathway (UPP) and Transcriptional Regulation 
 Genetic studies in yeast have shown that cells cannot survive without functional 
proteasomes. Proteasomes are involved in a number of vital cellular functions including 
transcription, the cell cycle, DNA repair, apoptosis, antigen processing, development, 
degradation of misfolded proteins and protein turnover (Lodish, 2000). To emphasize the 
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transcriptional aspect of the ubiquitination-proteasome pathway (UPP), the 
transcriptional activity of most NRs is dependent on functional and active UPP 
components. 
Proteasome Structure and Ubiquitination Cascade 
 The 26S proteasome holoenzyme is comprised of one or two 19S regulatory 
particles or caps, with ‘lid’ and ‘base’ subunits, which surround a 20S catalytic core; an 
11S regulator that is involved in antigen presentation, but not protein degradation, is 
present in mammalian proteasomes (Kinyamu et al., 2005). The lid of the 19S caps has 
eight non-ATPase subunits and one unique subunit and is essential for degradation of 
polyubiquitinated substrates. The base of the 19S caps, important in recognition of 
ubiquitinated substrate by the proteasome, has six AAA ATPase subunits and three non-
ATPase subunits. ATP hydrolysis by the caps provides the energy to unfold protein 
substrates and transfer them into the 20S core. The 20S core is comprised of 14 subunits, 
two α rings with seven distinct subunits, α1-7, surrounding two β rings with seven 
distinct subunits, β1-7, on either side in a barrel structure. The α rings do not possess 
catalytic activity; however, they are thought to help facilitate the interaction between the 
20S and 19S proteasome components. Three of the seven β1-7 subunits have proteolytic 
active sites capable of cleaving after hydrophobic, acidic, or basic residues in a 
polypeptide due to chymotrypsin-like activity, caspase-like activity, and trypsin-like 
activity, respectively (Kinyamu et al., 2005). Cleavage leaves short peptides, which are 
released and further degraded by cytosolic peptidases.  
 Proteins that enter the catalytic chamber are polyubiquitinated with at least 5 
molecules of the 76-residue ubiquitin polypeptide in a process involving a specific 
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enzyme cascade (Lecker, 2006). Ubiquitin-activating enzyme (E1) is activated by 
thioester bond formation between the C-terminal end of ubiquitin and a cysteine residue 
on E1 in an ATP-dependent process. Activated ubiquitin is transferred to a cysteine 
residue on ubiquitin-conjugating enzyme (E2) by the formation of another thioester bond. 
In the last step in the cascade, the C-terminal glycine carboxy group of ubiquitin is 
attached to the ϵ-amino group of lysine residues or the amino group at the N terminus of 
the substrate protein through isopeptide bond formation catalyzed by ubiquitin ligase 
(E3) (Cadwell and Coscoy, 2005). Alternatively, E2 can catalyze ubiquitin transfer 
directly to a substrate protein through the formation of another isopeptide bond in a less 
common ubiquitination event. The direct interaction of the E3 enzyme with substrate 
confers substrate specificity to the UPP. This enzyme cascade synthesizes a polyubiquitin 
chain by transferring activated ubiquitin molecules to a lysine of the ubiquitin moiety 
previously linked to the target protein. These polyubiquitin tags are recognized by the 
19S proteasome caps which unfold and transport polyubiquitinated proteins into the 
catalytic core for degradation. Deubiquitinase enzymes and isopeptidases in the 
proteasome cap remove the ubiquitin chain from the protein and hydrolyze the bonds 
between individual ubiquitin groups. Ubiquitinated proteins must have a specific E3 
recognition motif and one or more ubiquitin-anchoring groups (Ciechanover, and Ben-
Saadon, 2004). 
UPP Effects on Transcriptional Activity of different Nuclear Receptors and Histones 
 In addition to the polyubiquitin tag, many unstable proteins contain PEST motifs, 
consisting of proline, glutamic acid, serine and threonine. These PEST motifs have a dual 
functionality as they can be phosphorylated and ubiquitinated, promoting degradation by 
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the UPP (Subramanian, 2012; Rechsteiner, 1990; Salghetti et al. 2001). This duality has 
important implications for transcriptional activity, as phosphorylation is thought to be 
involved in substrate recognition by the enzymes in the UPP and plays a vital role in the 
ligand-mediated stability of NRs. The overlap between sequences marking a protein for 
degradation in transcriptional activators and transcriptional activation domains is 
prominently displayed by the glucocorticoid receptor (GR) (Salghetti et al. 2001; 
Muratani and Tansey 2003). Normal GR is hyperphosphorylated and degraded via the 
UPP upon ligand-binding; however, both GR degradation and GR-mediated 
transcriptional activity is inhibited by mutation to its PEST motif (Kinyamu et al., 2005). 
 In addition to NR turnover, the proteasome plays an important role in 
transcription by facilitating turnover of many components of the transcription machinery, 
including the large subunit of RNA polymerase II (Huibregtse et al., 1997) and other 
associated transcription factors, like signal transducer and activator of transcription 5a 
(STAT5a) and Fos/Jun (Kim and Maniatis, 1996; Palombella et al., 1994). These UPP 
enzymes can interact with NRs and regulate their transcriptional activity in a number of 
ways, including: promoting degradation of negative regulators of gene transcription; 
recycling of factors exerting a positive influence on transcription, like NRs, general 
transcription factors and coactivators; disrupting the preinitiation complex enabling 
transcriptional elongation; or degradation of the elongating form of RNA polymerase II 
allowing an indefinite number of transcription reinitiations (Yan et al., 2003). 
Transcriptional elongation requires phosphorylation of the carboxy-terminal domain 
(CTD) of the largest subunit of RNA polymerase II, which, further demonstrating the 
association between ubiquitination and phosphorylation, causes the largest subunit to be 
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ubiquitinated. The phosphorylated and ubiquitinated CTD then recruits a number of 
elongation factors which can themselves impact the state of chromatin compaction and 
serve as substrates for kinases and UPP enzymes in close proximity (Gerber and 
Shilatifard, 2003). The phosphorylation capacity of the ATPase components of the 19S 
proteasome cap illustrates the close association between phosphorylation, ubiquitination, 
and proteasomal degradation. 
In accordance with the role of proteasomes in protein turnover of components of 
the transcriptional machinery, chromatin immunoprecipitation has shown that proteasome 
subunits cluster around the promoters for hormone-responsive genes (Stenoien et al., 
1999). This clustering allows various components of the UPP to act as coactivators; some 
notable components acting in this capacity are a ubiquitin-conjugating enzyme (UBC9), 
the E3 ubiquitin-protein ligases E6-associated protein (E6-AP) and receptor potentiation 
factor 1/reverse Spt phenotype 5 (RPF1/RSP5), and one of the ATPase subunits in the 
19S cap of the 26S proteasome, yeast suppressor for Gal 1/thyroid receptor interacting 
protein 1 (SUG1/TRIP1). As coactivators, these UPP components possess an array of 
enzymatic activity influencing chromatin compaction and thus the accessibility of genes 
to transcriptional machinery. This characteristic is important as genome organization into 
compact chromatin impedes transcription (Wolffe and Hayes, 1999). This enzymatic 
activity includes: histone acetyltransferase (HAT), phosphorylation, histone 
methyltransferase, sumoylation, ADP-ribosylation, ubiquitin-conjugation, and ubiquitin-
activation (Nathan et al., 2003).  
It has been proposed that coactivators exert a positive influence on transcription 
by physically bridging activated NRs and general transcription factors. Additionally, in 
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concert these catalytic chromatin modifying and NR bridging activities can stimulate 
transcription when assembled at hormone-responsive gene promoters, through 
nucleosome remodeling or covalent modification of other components of the 
transcriptional complex (Yan et al., 2003). Reinforcing the connection between the UPP 
and transcription is one of SUG1’s binding partners, Cdc68, an elongation factor and 
component of the facilitates chromatin transcription (FACT) complex (LeRoy et al., 
2000); yeast deficient in SUG1 and SUG2 are incapable of normal elongation (Ferdous et 
al., 2001). SUG1 binds directly to activation domains of Gal4 and viral activator VP16 
(Ferdous et al., 2002) and is recruited to the estrogen receptor-responsive pS2 promoter 
along with E6-AP and MdM2 (Perissi et al., 2004), in just one of many examples where 
various UPP enzymes are recruited to NR promoters. Another ATPase subunit in the base 
of the 19S cap, Rpt5/TBP-1 or HIV/tat-binding protein 1, was first defined as a 
modulator of HIV Tat transactivation by binding to and suppressing Tat-mediated 
transactivation (Kinyamu et al., 2005). There is ample evidence that the enzymes of the 
ubiquitin cascade and proteasomal components have varying levels of necessity and 
sufficiency for maintaining normal transcriptional patterns. 
 As mentioned above, the ubiquitination system also plays a role in histone 
modifications. A highly conserved coactivator called SAGA (Spt-Ada-Gcn5-
Acetyltransferase) that performs acetylation and ubiquitination demonstrates how 
differential ubiquitination patterns can regulate gene expression. The GCN5 subunit of 
SAGA catalyzes histone acetylation and recruits the basal transcription machinery. 
Deubiquitination of monoubiquitinated histones H2A and H2B can be carried out by 
human SAGA ubiquitin-specific protease (USP), USP22, in a deubiquitination module 
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with ATXN7, ATXN7L3, and ENY2. While the function of ubiquitinated histones 
remains to be described, ubiquitinated H2B was found throughout the genome in 
association with transcribed regions of highly expressed genes, and SAGA 
deubiquitination activity is required for full transcriptional activity mediated by NRs 
(Zhao et al., 2008); both of these observations and documentation of ubiquitination of 
histones H3 and H1 (Pham and Sauer 2000) lend credibility to the hypothesis that 
ubiquitination may be an influential force modulating transcription. USP22 is dependent 
on the presence of the rest of the components of the deubiquitination module for 
integration into SAGA (Lang et al., 2011) and activation and an integrated USP22 has 
been shown to be necessary for the transcription of target genes regulated by sequence-
specific activators that require SAGA activity (Zhang et al., 2008). The deubiquitination 
activity of SAGA is directed more toward ubiquitinated H2B than H2A; however, cycles 
of ubiquitination and deubiquitination at the promoters and transcribed regions of SAGA-
regulated inducible genes are required to fully activate these genes (Lang et al., 2011).  
 The impact of ubiquitination on NR-mediated gene expression extends beyond the 
deubiquitination activity of SAGA. Some reports demonstrate colocalization of 
ubiquitinated histones to inactive transcriptional regions. Ubiquitinated histone H2A has 
been found in transcriptionally inactive compartments, conflicting data suggest that it is 
involved in chromatin rearrangement during spermatogenesis, a process regulated by 
androgen and estrogen receptors (Baarends et al.,1999). Ubiquitinated histone H3 is also 
found in elongating spermatids (Chen et al., 1998). Monoubiquitinated histone H1 causes 
its release from DNA, reducing chromatin condensation and leading to gene activation 
(Allison, 2012). Other studies have shown that ubiquitination of histone H2B is 
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associated with methylation of histone H3 at specific lysine residues, which may either 
stimulate or repress transcription (Briggs et al., 2002). These studies are significant for 
NR-mediated gene transcription, as NR function can be controlled by the complex 
interactions between different histone modifications in cross-talk pathways (Ma et al., 
2001). For instance, in Saccharomyces cerevisiae methylation of histone H3 at lysine 
residues K4 and K79 depends on ubiquitination of histone H2B, which is necessary for 
recruitment of proteasome subunits. Mutations in the ATPase subunits, Rpt4 and Rpt6, 
disrupt histone H3 methylation without altering histone H2B ubiquitination. The 
involvement of histone H2B ubiquitination in proteasome subunit recruitment and histone 
H3 methylation hints that the potential for transcriptional modulation through 
ubiquitination may be vast (Ezhkova and Tansey, 2004). 
 TR is a necessary transcription factor in the expression of genes under the control 
of a TRE, suggesting the possible impact that the aforementioned UPP transcriptional 
regulation methods could have on the expression of T3-responsive genes. Experimental 
data have already shown that SUG1 has a stimulatory effect on TR transcriptional 
activity (Fraser et al., 1997); furthermore, Rpt5 interacts with TR and enhances TR-
mediated transcription cooperatively with SRC-1. Knockout of Rpt5 disrupts ligand-
induced loading of TR, SRC-1, and RNA polymerase II (Satoh et al., 2009). 
Additionally, the E2 enzyme Ubc2 and E6-AP are necessary for TR transcriptional 
activation (Perissi et al., 2004), demonstrating how important functional UPP 
components are to TR-mediated transactivation. Conversely, proteasome inhibition 
significantly diminishes the ligand-induced transcriptional activity of many NRs 
including TR (Ramamoorthy and Nawaz, 2008). Ultimately, transcriptional activity in the 
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face of proteasome inhibition is NR-specific as glucocorticoid, estrogen and progesterone 
receptor recycling is stimulated by agonist ligand; however, estrogen and progesterone 
receptor transcriptional activity is impaired whereas GR is not (Nawaz et al. 1999, 
Wallace & Cidlowski 2001, Deroo et al. 2002).  Interestingly, proteasome inhibition has 
a stabilizing effect on many coactivator proteins, including E6-AP, suggesting that the 
enzymes of the ubiquitination cascade are not exempt from destruction by the UPP.  
 
Linking TR Misregulation and Mutation to Disease 
 The indirect and direct involvement of T3 and TR in numerous pathways 
underscores how misregulation of the T3-TR system could have a multitude of deleterious 
consequences affecting a wide variety of cellular processes. Resistance to Thyroid 
Hormone (RTH) is a prominent clinical condition associated with suboptimal T3 nuclear 
action; there are many different types of receptor mutations that have been found in RTH 
patients. One current study has found a heterozygous missense mutation (Ala263Val) in 
both TRα1 and TRα2 proteins. Transcriptional function of wild-type TR is inhibited by 
the dominant-negaive Ala263Val mutant TRα1, whereas TRα2 Ala263Val mutant 
function matched that of wild-type TRα (Moran et al., 2014). Another clinical 
investigation reported a de novo heterozygous nonsense mutation in the gene encoding 
TRα, leading to an increased affinity for the NCoR and SMRT corepressors, failed T3-
dependent corepressor disassociation, and a reduced affinity for coactivator SRC-1. 
These changes led to dominant negative inhibition of the wild-type receptor (Bochukova 
et al., 2012). Additionally, a defect in the LBD of TRβ, a glycine-arginine substitution 
resulting from a single guanine-cytosine replacement in the codon for amino acid 340, 
has also led to RTH development (Sakurai et al., 1989). Although this is one of many 
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characterized TRβ mutations leading to RTH. The symptoms of RTH include goiter, 
elevated circulating thyroid hormone levels, nonsuppressed serum TSH level, clinical 
euthyroidism, and tachycardia (Refetoff et al., 2007). 
 Similar to the genetic basis for RTH, abnormal signaling patterns and TR 
mutations have been documented in several forms of cancer. One form of mutant TRβ in 
knock-in mice, created after observing an RTH patient with the same mutation, has lost 
T3 binding activity and transactivation capacity and invariably develops thyroid cancer 
(Furuya et al., 2007). Other TRβ mutations have been seen in cases of hepatocellular 
carcinoma, renal cell carcinoma, and erythroleukemias (Rosen et al., 2011; Chan and 
Privalsky, 2010). Many of these cancers are the result of direct interaction between the 
TRβ mutant and the regulatory p85α subunit of phosphatidylinositol 3-kinase (PI3K); 
PI3K is activated during this interaction leading to increased phosphorylation of Akt and 
mTOR and subsequent cellular proliferation and migration (Furuya et al., 2009). In 
addition to the oncogenic isoform of TRα, v-ErbA, tumorigenesis in intestinal epithelial 
cells has been linked with TRα stimulation of transcription of the β-catenin gene 
(Plateroti et al., 2006). 
 Interestingly, CRM1 facilitates the nuclear export of many cancer-associated 
proteins (Nguyen et al., 2012). v-ErbA nuclear export is mediated through a CRM1-
dependent pathway, and coexpression of v-Erb-A with RXR or TR leads to their 
cytoplasmic sequestration and abnormal patterns of T3-responsive gene expression 
(Bonamy et al., 2005). Survivin, a regulator of cell division in the nucleus and an 
apoptosis inhibitor in the cytoplasm, depends on CRM1 for nuclear export and has a 
primarily cytoplasmic localization in cancerous cells (Altieri, 2010; Altieri, 2008). CRM1 
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inhibition or disruption of the NES, resulting in nuclear retention of Survivin, increased 
the susceptibility of cancer cells to chemotherapy and radiation (Chan et al., 2010). 
CRM1 appears to participate in a regulatory feedback loop with p53, a cell cycle 
regulator and tumor suppressor protein (Aylon and Oren, 2011). p53 function is 
dependent on nuclear localization, a localization pattern primarily regulated by CRM1, to 
function (Cai and Liu, 2008). Some cancer cells display altered p53 localization patterns 
and p53 dysfunction due to increased CRM1 levels; conversely, nuclear p53 can repress 
CRM1 transcription (van der Watt and Leaner, 2011; Stommel et al., 1999). Another 
CRM1 cargo, STAT1, has a functionality mirroring p53, inducing anti-proliferative and 
pro-apoptotic responses in tumor cells. In addition, another member of the STAT family, 
STAT3, has NES homology to STAT1 and was considered a potential CRM1 cargo. 
Mutagenesis studies, western blotting, and immunoprecipitation indicate that XPO7 is 
actually the main karyopherin used for STAT3 nuclear export. Furthermore, acetylation 
of STAT3 on a lysine is required for interaction with XPO7 (Schroder et al., 2014). Loss 
of STAT3 nuclear export by silencing XPO7 can affect STAT3 downstream gene 
expression (Reich et al., 2006).  
 The overlap between exportin dysregulation, acetylation, and misregulated gene 
expression is suggestive of a role for the UPP in contributing to the remediation or onset 
of disease as well as maintaining normal transcription. Beyond the potential involvement 
of UPP components in exportin-related diseases, the pathway has been implicated in the 
development of numerous other diseases including genetic disease like cystic fibrosis and 
Angelman's syndrome (Schwartz and Ciechanover, 1990), and neurodegenerative 
diseases like Alzheimer's disease, Huntington’s disease, and amyotrophic lateral sclerosis 
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(Ciechanover and Brundin, 2003). Mutations and deletions to the gene for the 
multifunctional Parkin RING finger ubiquitin ligase have been identified as major risk 
factors for the onset of Parkinson’s disease. Both decreases and loss of enzyme activity 
are associated with the development of Autosomal Recessive Juvenile Parkinsonism. One 
proposal suggests that mutated Parkin has a dominant-negative effect, binding and 
sequestering a substrate, but stabilizing it as a consequence due to an inability to 
ubiquitinate the substrate (Ciechanover and Brundin, 2003). Whatever the case, the UPP 
represents a system in which both proteasomal and ubitquitinating enzyme defects could 
contribute to various disease states and, paradoxically, serve as attractive therapeutic 
targets for disease states unrelated to UPP components. 
 
Thesis Objective 
 It is interesting to note that initial research classified TR as a chromatin-localized 
receptor (Oppenheimer and Samuels, 1983), especially since nucleocytoplasmic shuttling 
of TR is a critical factor in maintenance of cellular homeostasis (Bunn et al., 2001). 
Complex formation between T3 and TR and complex binding to TREs regulates gene 
expression. Conversely, TR is able to bind DNA in the absence of ligand and repress 
activity of its subject promoters (McKenna et al., 1999). How different factors influence 
the nuclear availability of TR is significant on a molecular and organismal level as 
misregulation can lead to a variety of thyroid-related illnesses including RTH, cancer and 
metabolic disease (Brent, 2012). The capacity for misregulation and mislocalization 
leading to disease is particularly prominent with the mutant TR variant, v-ErbA 
oncoprotein, which cannot mediate ligand-dependent transcriptional activation and 
competes for binding to TREs with normal TR-containing hetero- and homodimers (Yen 
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et al., 1994).  In addition, v-ErbA dimerizes with TRα and RXR, leading to their 
cytoplasmic sequestration (Bonamy et al., 2005).  
 Evidence from earlier Fluorescence Recovery after Photobleaching (FRAP) 
assays after knockdown of XPO7 by shRNA, suggested that XPO7 may play a role in a 
CRM1-independent nuclear export pathway (Subramanian et al., 2015), and preliminary 
experimentation yielded the finding that ubiquitinated TR bound to T3 localized to 
chromatin (Subramanian, 2012). This chromatin localization signifies a potent potential 
regulatory mechanism as components of the UPP have a widespread cellular distribution 
and tend to cluster around promoters for hormone-responsive genes (Stenoien et al., 
1999). More complete characterization of the array of XPO7 and UPP devices for 
regulation of gene expression may have important implications for similar systems 
involving other nuclear receptors.  
 This thesis research examined two potential regulators of TR nuclear availability, 
XPO7, which was hypothesized to promote increased TR nuclear export when 
overexpressed and to impact T3 mediated gene expression through TR nuclear export, and 
the UPP, which was hypothesized to impact transcriptional activity in a variety of ways, 
perhaps most notably by TR degradation. 
 
Materials and Methods 
Plasmids: Exportin 7 (RanBP16), TRα1, and TRβ1 plasmids were required for 
transfection and introduction of exogenous receptor and exportin to ascertain what effect 
exportin overexpression would have on TR localization patterns. The TRα1 plasmid used 
throughout the course of experimentation was pGFP-TRα1, encoding rat TRα1 tagged 
with green florescent protein (GFP) (Bunn et al., 2001). The TRβ1 plasmid, pGFP-TRβ1, 
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encodes GFP-tagged, human TRβ1 (Mavinakere et al., 2012). Two expression constructs 
of  HA-tagged human exportin 7, pMT2SM-RanBP16 and pCDNA3.1-RanBP16, were 
gifted to the Allison Lab from Dr. C. Smas (University of Toledo College of Medicine, 
Ohio). 
 An HA-tagged control plasmid, pCMV-HA, purchased from BD Biosciences (San 
Jose, CA) was used as a control for immunofluorescence, fixing, and localization assays. 
Chloramphenicol acetyltransferase (CAT) enzyme-linked immuno-sorbent assays 
(ELISA) required a CAT reporter gene linked to an empty vector as a control, and CAT 
reporter gene linked to a TRE enhancer for experimental conditions. The control 
pCAT®3-Basic Vector was supplied by Promega (Madison, WI). Experimental tk-TREp-
CAT plasmid is a TRE linked with herpes simplex virus thymidine kinase (tk) promoter-
CAT fusion gene reporter and was given to the Allison Lab by R. Evans (Salk Institute 
for Biological Studies). An HA-tagged ubiquitin plasmid, pHA-Ubiquitin, gifted to the 
Allison Lab by K. Fryrear (EVMS), was also used in CAT ELISAs. 
 Plasmids were purified with Qiagen midi- and mini-prep kits after plasmids were 
transformed into E. coli DH5α cells and given time to multiply in culture. Purification 
was performed in accordance with the Qiagen-plasmid purification protocol and plasmid 
purity and yield was assessed with a NanoDrop ND-1000 spectrophotometer. 
 
Cell Culture: HeLa cells (ATCC #CCL-2) were cultured in Nunc filter-capped flasks and 
Gibco Minimum Essential Medium (MEM) with Invitrogen Fetal Bovine Serum (FBS) to 
70-90% confluency, at which point, the extracellular matrix proteins enabling adherence 
to the flask surface were digested with Trypsin serine protease. Trypsinization involved 
aspiration of MEM, then washing the HeLa cells in approximately 15 mL Dulbecco’s-
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Phosphate Buffered Saline (D-PBS)(0.10 g KC1, 0.10g KH2PO4, 4.00 g NaCl, and 1.08 g 
Na2PO47 H2O in 500 mL), taking care to add D-PBS to the side of the flask opposite cell 
adherence. Following the D-PBS wash, flasks underwent two successive incubations. The 
first incubation occurred at room temperature in approximately 2 mL 0.25% Trypsin 
which was then aspirated. The second two minute incubation occurred in a 
ThermoScientific incubator at 37°C temperature, 98% humidity, and 5% CO2. Dislodged 
viable HeLa cells had a rounded morphology and appeared distinct from the flask 
surface. These dislodged cells were resuspended in 8 mL of MEM. A portion of the 
resuspended cells were transferred to six-well (Costar) or 100 mm vented plates. Seeding 
required extraction of 20 µL of this resuspension for cell counts with a hemocytometer. 
Round Coverslips for Cell Growth (Fisher) were added to each well in the six-well plates 
and seeded at a density of 2.4-3.2 x 105 cells per well in 2 mL MEM. A similar procedure 
was used to seed 100 mm plates; resuspended cells were seeded at approximately 6.0-7.0 
x 105 cells per plate in a total volume of 10 mL MEM. Cell vessels were incubated in the 
ThermoScientific incubator at the conditions listed above. Tissue culture work was 
performed in a Labconco Cabinet following Biosafety level II protocol. 
 
Transient Transfection: Transient transfection was used to overexpress proteins and 
assess their localization patterns and expression levels through fixation, staining and 
immunofluorescence and CAT ELISAs. Transfections were performed on HeLa cells that 
had reached 70-80% confluency in the wells of a six-well plate or a 100 mm plate. In 
conditions requiring the overexpression of only one plasmid, 2 µg of one type of plasmid 
DNA was diluted in 250 µL Invitrogen Opti-MEM Reduced Serum Medium (Opti-
MEM). For cotransfections, 1 µg of each type of plasmid DNA was diluted in 250 µL 
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Opti-MEM. Transfections can be facilitated through electrical or chemical means by use 
of electroporation or calcium chloride, in this case, Invitrogen Lipofectamine 2000 (Lipo) 
was used to facilitate transfection through the formation of liposome-DNA complexes 
taken up by endocytosis. 4 µL Lipo was diluted in 246 µL Opti-MEM; this Lipo dilution 
and the plasmid dilutions were incubated separately at room temperature for 5 minutes 
and then combined and incubated at room temperature for another 20 minutes. These 
transfection sets with a total volume of 0.5 mL were added to each well for six-well plate 
transfections and fixation, staining, and immunofluorescence assays. Transfection 
mixtures were incubated in the six-well plates for 6 hours in the ThermoScientific 
incubator at the conditions listed above before the transfection medium was aspirated and 
replaced with 2 mL MEM in each well. Transfections in preparation for exportin 7 CAT 
ELISAs called for a slightly different protocol in which 3 plasmids were used in each 
transfection and 3.33 µg of each type of plasmid DNA, 9.99 µg of plasmid DNA total, 
was diluted in 1.25 ml Opti-MEM, and 20 µL Lipo was diluted in 1.25 ml Opti-MEM. 
After the separate and combined incubations as described above, the transfection volume 
of 2.5 mL was added to each plate, already containing 10 mL MEM. This transfection 
procedure was mirrored in proteasome inhibition CAT ELISAs; however, there were only 
two plasmids used in the proteasome inhibition transfection, meaning transfections 
consisted of 6.66 µg each of two types of plasmid DNA. Transfections in preparation for 
ubiquitination CAT ELISAs alternated between transfection with two plasmids for 
certain plates, requiring 6.66 µg of plasmid DNA, and three for others, requiring 9.99 µg 
of plasmid DNA. 
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Fixation, Staining, Immunofluoresence, Fluorescence Microscopy and Cell Scoring: To 
give the transfection procedure sufficient time for transcription and translation of 
episomal plasmid, the transfected samples were incubated in the ThermoScientific 
incubator for approximately 24 hours before being fixed and stained. Before fixation and 
staining, seeded coverslips in each well of a six-well plate were checked for adequate 
confluency. With the exception of initial medium aspiration, which was performed in the 
Labconco Cabinet, the remainder of the procedure was performed outside tissue culture 
conditions. Following media aspiration, each well, and thus each seeded coverslip, was 
washed three times with 2 mL 1 X D-PBS for 15 seconds. Cells were subsequently fixed 
in a Fisher Hamilton fume hood for 7 minutes in 3.7% formaldehyde solution, diluted in 
1 X D-PBS. Following the fixation period, the formaldehyde solution was pipetted out of 
each well in the fume hood and disposed of in the appropriate waste container. Returning 
to the lab bench, cells were rinsed three times for 5 minutes each in 2 mL 1 X D-PBS. 
After aspirating the last D-PBS wash from the wells, cells were permeabilized by one 
five minute wash in 0.2% Triton-X-100 solution, diluted in 1 X D-PBS, which was 
subsequently aspirated from each well. The cycle of three 5-minute washes in 2 mL 1 X 
D-PBS was repeated and the last D-PBS wash was left in each well to ease coverslip 
removal and inversion with tweezers on a 30 µL drop of 1:50 diluted primary antibody 
solution composed of 1 X D-PBS, Invitrogen 1.5% Normal Goat Serum, and the 
antibody. The primary antibody used in this case was a rabbit polyclonal antibody to the 
HA tag (Abcam #ab9110), as both the control and exportin plasmid encode HA tags. The 
inverted coverslips were incubated on the primary antibody solution for one hour in a 
humidified chamber, consisting of parafilm placed on top of a wet paper towel in a 
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Tupperware container. Tweezers were used to replace coverslips in the six-well plate 
cell-side up and subjected to another cycle of three 5-minute washes in 2 mL 1 X D-PBS. 
A second 45 minute incubation in a dark, humidified chamber on a secondary antibody 
solution was then performed by removing coverslips from wells with tweezers and 
inverting them on a 45 µL drop of a 1:100 secondary antibody dilution. The secondary 
antibody dilution was composed of secondary antibody (Vector Laboratories, T1-1000, 
Texas Red anti-rabbit IgG [H+L]), 1 X D-PBS, and 1.5% normal goat serum. Following 
the second incubation, coverslips were removed from the humidified chamber, and 
replaced, cell-side up in the six-well plate. Another cycle of three 5-minute washes in 2 
mL 1 X D-PBS was performed. Coverslips were removed from the wells and one edge 
was placed on a Kimberly-Clark KimWipe to remove excess liquid before mounting in 
an 8 µL drop of Fluoro-Gel II (Electron Microscopy Sciences) with 4, 6-diamidino-2-
phenylindole (DAPI) (2 µL of 0.25 µg/µL DAPI stock per 1 mL Fluoro-Gel II) on a 
Fisherfinest, Fisher Scientific glass slide. These slides were labeled and stored in a slide 
box at 4oC for about 24 hours prior to scoring via fluorescence microscopy to allow the 
mounting medium to harden. 
 These slides were blinded and then scored with an inverted Nikon Eclipse 
TE2000E fluorescence microscope using the inverted 60 X Oil Immersion objective. 
Counter stain DAPI allows stained nuclei to be seen with the UV-2E/C light filter block. 
Transfection with GFP-tagged TR required use of the FITC B-2E/C light filter block to 
excite (Blue Excitation) the green fluorescent tag and observe intracellular TR 
localization. Confirmation of cotransfection with GFP-tagged TR and HA-tagged 
exportin 7 was provided by observing the cells under the Red Excitation TRITC T-2E/C 
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light filter block. Cells were photographed with a Nikon AlRsi microscope Ti-E-PFS 
camera, with a 40X water objective. NIS-Elements 2.30 software and Adobe Photoshop 
CS were used to refine images and Microsoft Excel was used to construct bar graphs. 
 At least 100 cells per slide were counted and classified into one of three TR 
localization categories in a minimum of three replicate trials: Nuclear greater than 
cytoplasmic (N > C), cytoplasmic and nuclear (N + C), and cytoplasmic greater than 
nuclear (C > N). Post-scoring, the blinded designators for each slide were removed and 
statistical tests including averages, standard deviation, standard error, and unpaired 
Student’s t tests with the two tailed P value were performed with Microsoft Excel. 
 
CAT ELISAs: Chloramphenicol acetyltransferase (CAT) enzyme-linked immuno-sorbent 
assays (ELISA) are a convenient method for quantifying TRE activity by measuring the 
amount of CAT protein present in lysates from cells transfected with CAT reporter gene 
under control of a TRE. As CAT is a bacterial enzyme without a eukaryotic equivalent, 
its presence in transfected HeLa cells indicates enhancer activity, which for TREs, is 
dependent on TR availability. Thus CAT protein levels are indicative of TR presence in 
the nucleus. Over the course of experimentation, three separate sets of CAT ELISAs (Kit 
purchased from Roche Applied Sciences) were performed to explore different aspects of 
TR transcriptional availability and activity. The first set of CAT ELISAs was performed 
to assess how exportin 7 impacted TR localization. Preliminary data indicated that 
ubiquitinated TR was bound to chromatin in the presence of T3 (Subramanian, 2012), the 
second and third sets of CAT ELISAs sought to evaluate the relevance of ubiquitination 
to T3-mediated gene expression via treatment of transfected cells with proteasome 
inhibitors and lastly, transfection with ubiquitin plasmid to induce ubiquitin 
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overexpression. The transfection procedure varied between different CAT ELISA sets 
and will be addressed in the following passages. 
 For the exportin 7 CAT ELISAs, each experiment replicate required six 100 mm 
plates seeded with 6.0-7.0 x 105 cells per plate in 10 mL MEM. Transfections were 
performed approximately 24 hours after seeding with the plates incubated in a 
ThermoScientific Incubator (conditions listed above) in the intervening time. There were 
two groups of control transfections and one experimental transfection with two plates in 
each group, a plate without additional T3 added and a plate to which exogenous T3 had 
been introduced. The first control group of plates was transfected with 3.33 µg of each of 
the following plasmids according to the procedure described under “Transient 
Transfection”: pCAT®3-Basic Vector, pCMV-HA, and pGFP-TRα1. The second control 
group of plates was transfected with 3.33 µg of each of the following plasmids: tk-TREp-
CAT, pCMV-HA, and pGFP-TRα1. The experimental group was transfected with 3.33 
µg of each of the following plasmids: tk-TREp-CAT, pMT2SM-RanBP16, and pGFP-
TRα1. 
 The second CAT ELISA set required the same procedure (see “Transient 
Transfection”); however, there were only four plates used in each experiment replicate in 
the second CAT ELISA set. All plates were initially transfected only with 3.33 µg pGFP-
TRα1 and 3.33 µg tk-TREp-CAT. 
 The third CAT ELISA set had an identical transfection procedure to the one 
implemented in the second set; however, 3.33 µg of pHA-Ubiquitin was also added to 
two of the four plates in each experiment replicate. 
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 Each set of CAT ELISAs was incubated for 6 hours in the ThermoScientific 
Incubator (conditions listed above) before the media containing the Opti-MEM was 
removed and replaced with 10 mL MEM per plate. At 12 hours post-transfection, the 
media was aspirated and replaced with 10 mL 10% Charcoal-Dextran Stripped FBS (Life 
Technologies) in MEM (CD-Stripped MEM) per plate. During the second media change, 
10 µL of 100 µM T3 was added to one of the plates in each group from the first CAT 
ELISA set; T3 was added to half of the plates in the second and third CAT ELISA sets 
during the second media change. Additionally, 10 µL of 100 µM MG132, a potent 
proteasome inhibitor, was added to half of the plates in the second CAT ELISA set at this 
time. MG132 was dissolved in ethanol. To control for this addition, 10 µL 100% ethanol 
was added to plates that did not receive MG132. After the second media change, the 
plates were incubated in the ThermoScientific incubator (conditions listed above) for 12 
hours before the CAT ELISA procedure, identical for each CAT ELISA set, was begun. 
At 24 hours post-transfection, medium was aspirated from each plate in the 
Labconco Cabinet. Plates were washed three times with 5 ml of pre-chilled 1 X D-PBS, 
taking care to add buffer to the side of the plate to avoid disturbing the cells. Cell lysis 
involved adding 1.0-1.5 mL 1 X Lysis Buffer to each plate, making sure it washed over 
the entire plate, and a 30 minute incubation on ice. Cells were then scraped off of each 
plate using a Fisherfinest, Fisher Scientific sterile cell scraper, and the lysed cells 
suspended in lysis buffer were pipetted into 2.0 mL Eppendorf tubes, incubated at room 
temperature for 7 minutes and centrifuged for 10 minutes at 14000 x g and either 4°C or 
20-25°C. After centrifugation, the supernatant was transferred to 1.5 mL Eppendorf tubes 
and protein concentration was determined with the Pierce BCA Protein Assay. Working 
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Reagent and Bovine Serum Albumin (BSA) Standards were prepared fresh for each CAT 
ELISA trial. Standards had BSA concentrations of 0, 25, 125, 250, 500, 750, 1000, 1500, 
2000 μg/mL. 25 μL of each standard or unknown sample was pipetted into a microplate 
(Nunc) well. 200 μL of Working Reagent was then added to each well and the microplate 
was mixed gently for 30 seconds. The microplate was covered with parafilm and 
incubated at 37°C for 30 minutes, cooled to room temperature, and the absorbance of 
each standard or unknown was measured at 560 nm with a microplate reader (GloMax 
Multi-Detection System, Promega). The protein concentration of the samples was 
determined by interpolation from the absorbance line created by the BSA samples and 
blank. Protein concentrations for each sample were standardized and a CAT Enzyme 
working dilution was prepared fresh for each experiment. Preparing the working dilution 
involved dilution of a 40 μL CAT stock solution in 3.96 mL sample buffer to create 
working dilution samples with CAT concentrations of 0, 0.125, 0.25, 0.5, and 1.0 ng/mL. 
200 μL of CAT standards, a blank (3,3′,5,5′-Tetramethylbenzidine or TMB) 
(Sigma-Aldrich), or cell extracts were pipetted into each well and the plate was covered 
with foil. Two wells were filled with blank and two with each standard or cell extract. 
The microplate, with anti-CAT antibodies adsorbed onto the base of each microplate 
well, was incubated for one hour at 37°C before solution removal and rinsing of each 
well five times for 30 seconds each with 250 μL 1 X Washing Buffer. 200 μL anti-CAT-
digoxygenin (Anti-CAT-DIG) working dilution was then added to each well, the 
microplate was covered in foil and another hour-long incubation at 37°C was performed 
followed by anti-CAT-DIG solution aspiration and an identical wash cycle to the one 
performed after the first hour-long incubation: rinsing of each well five times for 30 
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seconds each with 250 μL 1 X Washing Buffer. 200 μL anti-DIG-peroxidase (POD) 
working dilution was then added to each well, and the microplate was covered in foil and 
incubated for one hour at 37°C. Another wash cycle ensued, and after the last wash was 
removed 100 μL TMB was pipetted into each well and incubated at room temperature for 
approximately 15 minutes, until the pronounced color change was complete. The reaction 
was stopped by adding 100 μL 2M sulfuric acid to each well and the absorbance at 450 
nm was read against TMB reagent blank with a GloMax Multi-Detection System 
(Promega). The absorbance measurements were averaged and used to determine relative 
CAT expression in each sample with Microsoft Excel. Further statistical testing was 
performed using Microsoft Excel (described in Fixation, Staining, Immunofluoresence, 
Fluorescence Microscopy and Cell Scoring). 
 
Results 
Exportin 7 Facilitates TR Nuclear Export 
Data from previous fluorescence recovery after photobleaching (FRAP) 
experiments indicated that exportin 7 (XPO7) may be involved in TR nuclear export, as 
XPO7 knockdown resulted in slower TRα1 shuttling dynamics as compared to the 
control (Subramanian et al., 2015). Transient transfection, immunofluoresence assays, 
and fluorescence microscopy were performed to better understand the impact of XPO7 on 
nucleocytoplasmic shuttling of TR. Two sets of control cells for both TRα1 and TRβ1 
were used in the transfection assays; the first control set was only transfected with either 
pGFP-TRα1 or pGFP-TRβ1 to demonstrate the baseline intracellular distribution of TR. 
The second control set was cotransfected with either pGFP-TRα1 or pGFP-TRβ1 and 
pCMV-HA to ensure that the HA-tag alone did not have an effect on TR distribution. The 
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experimental sets were cotransfected with either pGFP-TRα1 or pGFP-TRβ1, and an 
expression plasmid for HA-tagged XPO7 either in the vector pMT2SM or pCDNA3.1 to 
ensure that the particular clone used did not affect expression levels or function of XPO7. 
After immunostaining with anti-HA antibodies to detect the HA tag and confirm 
cotransfection, successfully cotransfected cells were scored for TR distribution by 
fluorescence microscopy. Three localization categories were used in scoring: nuclear 
greater than cytoplasmic (N>C), cytoplasmic and nuclear (N+C), and cytoplasmic greater 
than nuclear (C>N). Using scoring data from at least four experimental replicates, overall 
a significantly greater percentage of cells cotransfected with XPO7 showed a more 
cytoplasmic distribution of TR (Figure 1 A and B).  
 The averages from five replicates performed with XPO7 in the pMT2SM vector 
showed a statistically significant shift from 2.4% (±1.5%) of cells in the C>N category 
for the second control set, transfected with pGFP-TRα1 and pCMV-HA, to 28.2% 
(±5.4%) of cells in C>N category for the experimental set, transfected with expression 
plasmids for GFP-TRα1 and HA-tagged XPO7 (P = 0.0017) (Figure 1 A). These same 
assessments for TRβ1 showed a significant shift from 4.2% (±1.7%) of cells in the C>N 
category for the second control set, transfected with pGFP-TRβ1 and pCMV-HA, to 
41.4% (±3.7%) of cells in the C>N category for the experimental set, transfected with 
expression plasmids for GFP-TRβ1 and HA-XPO7 (P < 0.001). Conversely, there were 
significant shifts out of the N>C localization category in cotransfected cells expressing 
XPO7. Cells overexpressing XPO7 and GFP-TRα1 had 39.6% fewer cells in the N>C 
localization category than cells overexpressing only GFP-TRα1 (P < 0.001); a 30.8% 
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reduction in the N>C category was observed from cells overexpressing GFP-TRβ1 to 
cells overexpressing GFP-TRβ1 and XPO7.  
 The averages from four transfection and immunofluoresence replicates performed 
for XPO7 in the pCDNA3.1 vector showed a shift from 3.0% (±1.8%) of cells in the C>N 
category for the first control set, transfected with pGFP-TRα1, to 20.8% (±2.6%) of cells 
in C>N category for the experimental set, transfected with expression plasmids for GFP-
TRα1 and HA-XPO7 (P = 0.0012) (Figure 1 B). These same measurements for TRβ1 
showed a statistically significant shift from 15.5% (±1.9%) of cells in the C>N category 
for the first control set, transfected with pGFP-TRβ1, to 29.8% (±2.0%) of cells in the 
C>N category for the experimental set, transfected with expression plasmids for GFP-
TRβ1 and HA-XPO7 (P = 0.0013). A similar shift out of the N>C category in cells 
overexpressing XPO7 in the pCDNA3.1 vector and GFP-TRβ1, compared to control cells 
only overexpressing GFP-TRβ1 was observed; there was a 23.5% reduction in cells 
classified N>C from cells overexpressing GFP-TRα1 to cells overexpressing GFP-TRα1 
and HA-XPO7 and a 21.5% reduction for GFP-TRβ1 transfected cells in these categories. 
Taken together, these results provide evidence that exportin 7 plays a key role in 
facilitating TR nuclear export. 
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Figure 1 A and B. TR Localization with Exportin 7 in pMT2SM (A) and pCDNA3.1 (B) Transfection: Percent of cells in each 
localization category for transfection with XPO7 in two different vectors. Localization categories were: Nuclear>Cytoplasmic 
(N>C), Cytoplasmic and Nuclear (C+N), and Cytoplasmic>Nuclear (C>N). There were four sets of controls for each 
transfection: cells overexpressing pGFP-TRα1 or pGFP-TRβ1 alone, or cells overexpressing pGFP-TRα1 or pGFP-TRβ1 as 
well as pCMV-HA. Experimentally transfected cells overexpressed pGFP-TRα1 or pGFP-TRβ1 as well as pMT2SM-HA-
XPO7 (A) or pCDNA3.1-HA-XPO7 (B). Error Bars are Standard Errors of the Mean. For Exportin 7 in pMT2SM 
transfections, n = 5 replicates. For Exportin 7 in pCDNA3.1 transfections, n = 4 replicates. A minimum of 100 cells were 
scored per slide. 
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Variable Impact of Exportin 7 Overexpression on TRα1-Mediated CAT Reporter 
Gene Expression 
TR nuclear localization, complex formation with T3, and binding of the hormone-
receptor complex with a TRE is a necessity for transcription of T3-responsive genes (Liu 
and Brent, 2010). If XPO7 provided a CRM1-independent export pathway for TR, XPO7 
overexpression would be predicted to decrease expression of T3-responsive genes. This 
hypothesis was tested by performing CAT ELISAs, transfecting cells with a CAT 
reporter gene under positive control of a TRE, and quantifying CAT protein levels from 
whole cell lysates. Two sets of control cells were transfected with pCAT®3-Basic 
Vector, pCMV-HA, and pGFP-TRα1; another two sets of control cells were transfected 
with tk-TREp-CAT, pCMV-HA, and pGFP-TRα1. Two sets of experimental cells were 
transfected with tk-TREp-CAT, HA-XPO7, and pGFP-TRα1. One of each of the 
transfected cell sets was incubated with 100 nM T3 for 12 hours and then lysed to 
quantify CAT protein levels. Absorbance measurements from cell sets that had been 
incubated with T3 were divided by absorbance measurements from the cells in the set that 
had not been incubated with T3 to obtain relative CAT protein expression levels.  
 Comparing relative CAT expression of experimental cells overexpressing XPO7 
to the controls yielded variable results. Out of three replicates and four total trials, CAT 
protein levels were lower in cells overexpressing XPO7 relative to control cells also 
transfected with CAT reporter gene under positive control of a TRE in three trials. In one 
of the trials, the experimental set had almost double the level of CAT protein relative to 
the detected level of CAT protein in the control cells transfected with CAT reporter gene 
under positive control of a TRE. It seems unlikely that the ‘outlier’ assay was invalid or 
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false due to similar variability in results when a senior lab member performed the same 
assays1. Averaging the data from all trials and replicates led to a compilation 
demonstrating that XPO7 transfected cells had only slightly less CAT reporter gene 
expression, presumably by facilitating TRα nuclear export, but this trend was not 
statistically significant (Figure 2). The variability led to large standard deviation and 
standard error of the mean; even in the three trials with higher CAT expression in control 
cells, the quantified protein level was variable, ranging between 1.11 and 2.08 times 
higher CAT protein levels in control cells relative to experimental cells (P = 0.793). 
 
 
 
Figure 2. The Effect of Exportin 7 Overexpression on CAT Reporter Gene Expression in 
TRα1 Transfected Cells: The first bar represents relative CAT protein expression in 
control cells transiently transfected with pCAT®3-Basic Vector (EV), pCMV-HA (HA), 
and pGFP-TRα1 (GFP-TRα1). The second bar represents relative CAT protein 
expression in control cells transiently transfected with tk-TREp-CAT (pCAT), pCMV-
HA (HA), and pGFP-TRα1 (GFP-TRα1). The third bar represents relative CAT protein 
expression in control cells transiently transfected with pMT2SM-RanBP16 or 
pCDNA3.1-RanBP16 (XPO7), tk-TREp-CAT (pCAT), and pGFP-TRα1 (GFP-TRα1). 
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Relative CAT protein expression levels were determined by dividing absorbance 
measurements from plates to which T3 had been added from plates to which no T3 had 
been added; plates in the same set were transfected with the same plasmids, their 
treatment only differed in T3 addition. The error bars represent the Standard Error of the 
Means. n = 4 replicates. 
 
Increase in TRβ1-Mediated CAT Reporter Gene Expression Concurrent with 
Exportin 7 Overexpression 
Two sets of control cells were transfected with pCAT®3-Basic Vector, pCMV-
HA, and pGFP-TRβ1; another two sets of control cells were transfected with tk-TREp-
CAT, pCMV-HA, and pGFP-TRβ1. Two sets of experimental cells were transfected with 
tk-TREp-CAT, XPO7, and pGFP-TRβ1. One of each of the transfected cell sets were 
incubated with 100 nM T3 for 12 hours and then lysed to quantify CAT protein levels. 
The same procedure was performed with pGFP-TRβ1 transfected cells to obtain relative 
CAT protein expression levels as with pGFP-TRα1 transfected cells. Comparing relative 
CAT expression of experimental cells overexpressing XPO7 to the controls demonstrated 
consistently higher levels of CAT expression in experimental cells overexpressing XPO7. 
Out of four replicates and four total trials, CAT protein levels were significantly higher in 
cells overexpressing XPO7 relative to control cells also transfected with CAT reporter 
gene under positive control of a TRE. Consistency in CAT expression across the trials for 
control and experimental cell sets resulted in low standard error of the mean and low 
standard deviation. Combining the data from all trials yielded an average 1.89 fold 
increase in CAT expression in XPO7 transfected cells relative to control cells transfected 
with the TRE-CAT reporter gene plasmid (P = 0.00846) (Figure 3). 
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Figure 3. The Effect of Exportin 7 Overexpression on CAT Reporter Gene Expression in 
TRβ1 Transfected Cells: The first bar represents relative CAT protein expression in 
control cells transiently transfected with pCAT®3-Basic Vector (EV), pCMV-HA (HA), 
and pGFP-TRβ1 (GFP-TRβ1). The second bar represents relative CAT protein 
expression in control cells transiently transfected with tk-TREp-CAT (pCAT), pCMV-
HA (HA), and pGFP-TRβ1 (GFP-TRβ1). The third bar represents relative CAT protein 
expression in control cells transiently transfected with pMT2SM-RanBP16 or 
pCDNA3.1-RanBP16 (XPO7), tk-TREp-CAT (pCAT), and pGFP-TRβ1 (GFP-TRβ1). 
Relative CAT protein expression levels were determined by dividing absorbance 
measurements from plates to which T3 had been added from plates to which no T3 had 
been added; plates in the same set were transfected with the same plasmids, their 
treatment only differed in T3 addition. The error bars represent Standard Error of the 
Means. n = 4 replicates. 
 
Effect of Proteasome Inhibition on TR-Mediated CAT Reporter Gene Expression 
The interplay between the ubiquitin-proteasome degradation pathway and 
transcriptional activity of nuclear receptors is an area of ongoing research (Kinyamu et 
al., 2005; Ferdous et al., 2001; Ferdous et al., 2002; Gillette et al., 2004). Proteasomes in 
both the nucleus and cytoplasm are capable of liganded or unliganded nuclear receptor 
destruction; however, it is unclear whether TR ubiquitination and destruction occurs 
preferentially in a particular cellular compartment. Determining the extent to which the 
ubiquitination-proteasome pathway exerts control over TR availability is an important 
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aspect to consider in examining TR-mediated gene expression. As T3 accelerates 
proteasomal degradation of TR (Bondzi et al., 2011), CAT ELISAs were performed on 
cells treated with the proteasome inhibitor, MG132, and T3 to assess the effects that 
different treatment protocols involving the proteasome inhibitor and the hormone would 
have on TR transcriptional activity. All seeded plates were initially transfected with 3.33 
µg pGFP-TRα1 and 3.33 µg tk-TREp-CAT and CAT protein levels quantified by CAT 
ELISA; however, their treatment during the second media change varied. There were 
three control plates. The first control plate was not treated with T3 or MG132, the second 
was treated with 100 nM MG132, and the third was treated with 100 nM T3. The 
experimental plate was treated with both 100 nM T3 and 100 nM MG132. The plates 
were incubated with these treatments for approximately 12 hours before being lysed 
during the CAT ELISA. Results from 5 replicates and 9 trials were inconclusive. The 
experimental plates had higher CAT protein levels relative to the third control in only 
three trials. This would seem to indicate that proteasome inhibition has a negative impact 
on TR availability, however, there was a large amount of variability between trials and 
any differences were not significant (P = 0.667) (Figure 4). 
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Figure 4. The Effect of Proteasome Inhibition on CAT Reporter Gene Expression: The 
first bar represents relative CAT Protein Expression in control cells devoid of exogenous 
T3 or MG132. The second bar represents relative CAT protein expression in control cells 
to which MG132 but no T3 had been added. The third bar represents relative CAT protein 
expression in control cells to which T3 but no MG132 had been added. The fourth 
experimental bar represents relative CAT protein expression in experimental cells to 
which both T3 and MG132 had been added. Relative CAT protein expression levels were 
determined by dividing absorbance measurements from each plate by absorbance 
measurements from the first control plate. The error bars represent Standard Error of the 
Means. n = 5 replicates. 
 
 
Effect of Overexpressing Ubiquitin on TR-Mediated CAT Reporter Gene 
Expression  
Preliminary results from proteasome inhibition assays and immunoprecipitation 
and western blot data suggest that liganded and ubiquitinated T3 is bound to chromatin 
(Subramanian, 2012). These pilot studies led to the question of whether overexpressing 
ubiquitin would have an impact on CAT expression levels, especially since T3 presence 
has documented negative effects on TR half-life (Subramanian, 2012). To investigate this 
question a similar experimental design was used to the Proteasome Inhibition Assay 
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experimental design; there were four plates used in each trial: three control and one 
experimental. All of the plates were transfected with 3.33 µg pGFP-TRα1; however, the 
second control and the experimental plate were also transected with 3.33 µg pHA-
Ubiquitin. The first and second control did not receive additional T3 while the third 
control and experimental plates were incubated for approximately 12 hours with 100 nM 
T3.  
 As with XPO7 and proteasome inhibition CAT ELISAs, ubiquitination CAT 
ELISAs also had a high degree of variability and any differences were not significant (P 
= 0.901) (Figure 5). Out of seven replicates and 13 trials, six trials had higher quantified 
levels of CAT expression in the third control, treated with T3 but no pHA-Ubiquitin, and 
seven trials had higher expression in the experimental cells, treated with T3 and pHA-
Ubiquitin. 
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Figure 5. The Effect of Ubiquitination on CAT Reporter Gene Expression: The first bar 
represents relative CAT protein expression in control cells that had not been transiently 
transfected with pHA-Ubiquitin and lacked exogenous T3. The second bar represents 
relative CAT protein expression in control cells transiently transfected with pHA-
Ubiquitin to which T3 had been added. The third bar represents relative CAT protein 
expression in control cells transiently transfected with pHA-Ubiquitin to which T3 had 
been added. The fourth bar represents relative CAT protein expression in experimental 
cells transiently transfected with pHA-Ubiquitin to which both T3 had been added. 
Relative CAT protein expression levels were determined by dividing absorbance 
measurements from each plate by absorbance measurements from the first control plate. 
The error bars represent Standard Error of the Means. n = 7 replicates. 
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Discussion 
XPO7 Facilitates TR Cytosolic Localization Shift and Augments TR-mediated Gene 
Expression 
 
Fluorescence recovery after photobleaching (FRAP) experiments demonstrated 
that TRα1 shuttling dynamics were significantly slower with XPO7 knockdown 
(Subramanian et al., 2015). These prior findings combined with the observation that 
leptomycin B, a specific CRM1 inhibitor, is insufficient for complete inhibition of TR 
nuclear export (Bunn et al., 2001), led to further assays in this thesis research to assess 
the viability of XPO7 in providing a CRM1-independent nuclear export pathway for TR. 
Here, localization and fluorescence microscopy assays showed that TR had a 
significantly higher cytoplasmic and whole cell presence in cells overexpressing XPO7, 
compared to control cells. This data provides evidence indicating a role for XPO7 in 
facilitating TR nuclear export. 
Results from the localization and fluorescence microscopy assays led to the 
hypothesis that TR-mediated CAT reporter gene expression would decrease in cells 
overexpressing XPO7, as a smaller nuclear TR presence would seemingly lead to reduced 
capacity to complex with T3 and bind to TREs to activate gene expression. However, 
results from transcriptional assays were variable: there was no significant difference 
between TRα-mediated CAT expression in the presence or absence of XPO7, but TRβ-
mediated CAT expression was significantly increased in the presence of XPO7. The 
disparity in the consistency of the expression patterns between TRα and TRβ may be 
related to the use of different TREs for promoters of T3 target genes, which influences TR 
transcriptional activity (McKenna et al., 1999).  
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The contrasting localization and transcriptional activity data for TRα1, taken in 
consideration with the generality of XPO7 cargoes, suggests that XPO7 may be 
facilitating TR nuclear export while simultaneously facilitating nuclear export for 
corepressors of T3–responsive genes. If the amount of TR left in the nucleus were 
sufficient to enable transcription from TREs, the effect of corepressor removal may be 
more stimulatory to transcription than the inhibitory effect of TR export. This hypothesis 
seems particularly attractive in the context of TRβ, which displayed significant increases 
in CAT expression despite the cytoplasmic shift observed in cells overexpressing XPO7. 
Conservation of basic residues in the corepressor SMRT and its interaction partner in a 
repression domain, GPS2 provide support for the hypothesis that XPO7, seemingly 
dependent on basic residue recognition, may be facilitating corepressor nuclear export 
(Oberoi et al., 2011), creating a transcriptional setting conducive to stimulation of TRβ-
mediated gene expression.  Cytosolic localization and activation of the XPO7 cargo 
LKB1, increased by T3 in muscle, has been shown to enhance expression of TR 
coactivator peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), which 
stimulates TR-mediated gene expression. The corepressor SMRT undergoes a 
cytoplasmic shift in response to cellular activity (Guo et al., 2013). A plausible proposal 
for the cytosolic localization of TR in XPO7 overexpression and the simultaneous 
increase in TRβ-mediated gene expression may center on nuclear export of LKB1 
augmenting TR coactivator and inhibiting corepressor expression. 
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The Impact of Proteasome Inhibition and Ubiquitin Overexpression on 
Transcription 
The overlap of transcriptional regulation and degradation by the Ubiquitin-
Proteasome Pathway (UPP) in many facets of both processes complicates the 
determination of how experimental manipulation affects TR-mediated gene expression. 
CAT ELISA results suggest that neither proteasomal inhibition nor ubiquitin 
overexpression had a significant impact on CAT reporter gene expression under control 
of a TRE; however, this conclusion may be overly simplistic as these manipulations may 
activate contradictory mechanisms of transcriptional regulation. For instance, proteasome 
protease inhibitors increase the amount of ubiquitinated and non-ubiquitinated TRβ1 
present while decreasing T3
 dependent transcriptional activation (Dace et al., 1999). 
Similarly, proteasome inhibition increases cellular concentrations of RXR with no 
concurrent increase in transcriptional activation (Osburn et al., 2001). Proteasome 
inhibition likely increases the nuclear presence of TR; however; this increased receptor 
presence does not correlate to increased expression of a TRE-mediated reporter gene, 
possibly due to a requirement for repressor degradation by functional proteasomes for 
transactivation, or an accumulation of ubiquitin on TR, or coactivators interfering with 
their transcriptional activity.  
The complexity of these interactions is highlighted in the literature. For example, 
the transcriptional activity of the yeast transcription factor MET4 is directly inhibited by 
ubiquitination (Kaiser et al., 2000). In addition, ubiquitin overexpression may enhance 
pre-existing negative cross-talk interactions between receptors. Estradiol leads to 
estrogen receptor orchestration of a reduction in intracellular GR levels by increasing 
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expression levels of the E3 ubiquitin ligase, Mdm2 (Sengupta and Wasylyk, 2001). It 
wouldn’t be unreasonable to propose similar interactions between TR and other NRs, 
considering the extensive involvement of TR in multiple signal cascades. Similarly, 
histone modification cross-talk could also impact transcriptional activity of target genes 
under control of a TRE, as ubiquitination of histone H2B regulates histone H3 
methylation and gene silencing in yeast (Sun and Allis, 2002). Additionally, activation of 
the SAGA regulated genes GAL1, SUG2, and PHO5 is at least partially dependent on 
H2B-K123 ubiquitination (Henry et al. 2003), with activation of GAL1 gene being 
accompanied by dynamic changes in histone H2B ubiquitination levels. 
 Compounding the difficulty of ascertaining clear relationships between the UPP 
and the transcriptional entourage of TR target genes are the more well-characterized 
impacts of the UPP on transcription: promotion of degradation of negative regulators of 
gene transcription, degradation and recycling of positive factors, disruption of the 
preinitiation complex enabling transcriptional elongation, and degradation of the 
elongated form of RNA polymerase II allowing an indefinite number of transcription 
reinitiations (Yan et al., 2003). A multitude of these influences could be affecting TR-
mediated gene expression leading to a complex regulatory picture which cannot be 
properly detected or assessed with CAT ELISAs which may be insensitive to subtle but 
significant changes in gene expression. 
 
Conclusions 
The data presented in this thesis illustrate the intricacy of TR shuttling dynamics 
and transcriptional activity. In addition to the general CRM1 nuclear export pathway and 
exportin 5-mediated nuclear export, TR also may use XPO7 as an exportin. The 
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generality of XPO7 substrates hints that TR nuclear export may only be a small part of 
larger signal transduction cascades which may result in promotion of TR coactivator 
activity and inhibition of corepressor activity. Additional research is necessary to 
determine whether the UPP affects TR-mediated expression patterns and to what extent, 
although the potential for UPP influence seems vast in the context of its known 
transcriptional impacts. The involvement of TR in a number of physiological processes 
like embryonic development, cellular differentiation, metabolism, and cell growth is 
directly related to its nucleocytoplasmic shuttling capacity and regulation of receptor 
half-life by the UPP. As TRs can directly regulate transcription by binding to TREs of 
target genes, nucleocytoplasmic shuttling by the receptor serves as a method for 
stimulating or repressing target gene expression. The specificity of response to signaling 
cascades is enhanced by regulation of activities of several transcription factors through 
nucleocytoplasmic shuttling. Many NRs shuttle between the nucleus and cytoplasm 
which affects patterns of target gene expression; NR recycling by the UPP has emerged 
as another important regulatory device. Studies have shown that TRβ1 transcriptional 
activity is inversely correlated to receptor protein levels suggesting that proteasome-
mediated degradation plays a critical role in the transcriptional activation of TR. 
Furthermore, a mutated form of TRβ1 which does not have a decreased half-life in the 
presence of T3 as wild-type TRβ1 does, has been implicated in some RTH cases (Dace et 
al., 2000). 
 
Future Directions 
The low sensitivity of CAT ELISAs means that possible UPP impacts on T3-
mediated gene expression may have been obscured in the experiments performed over the 
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course of this thesis research. Luciferase assays are a more sensitive method for 
measuring transcriptional output (Adolph, 1996) and could be used to better ascertain the 
effects of proteasomal inhibition and ubiquitin overexpression on TR transcriptional 
activity. Should these assays demonstrate a significant UPP impact on TR transcriptional 
activity, co-immunoprecipitation and western blotting may better demonstrate which 
specific components of the UPP are interacting with TR and perhaps direct NR cross-talk 
interactions between TR and other NRs. Furthermore, pull-down or yeast two-hybrid 
assays could reveal whether or not the interaction between XPO7 and TR is direct and 
which NES or NESs in TR interact with XPO7, though mutagenesis studies could also be 
used to this end. Chromatin immunoprecipitation may demonstrate histone modification 
and histone cross-talk influencing chromatin compaction in promoters for T3–responsive 
genes. Though X-ray crystallography is outside the purview of this lab, resolution of 
XPO7 structure alone and complexed with TR would be immensely helpful in elucidating 
the details of the TR-XPO7 interaction. 
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